Welcome to Simcyp


population based pharmacokinetic modelling and simulation

home > research & development > publications > posters / abstracts


Posters / Abstracts

Simcyp Posters RSS

Please view our latest posters below:


  • Salem F, Barter ZE, Johnson TN & Rostami-Hodjegan A

    Nov 2008

    Theoretical assessment of metabolic drug interactions in paediatric population: the impact of age related fractional metabolism (fm) and its disparity between adults and neonates.
    PKUK Meeting
    November 26th-28th 2008, London Stanstead, UK.

    Available to Members only, click to login.

  • Rowland-Yeo K, Jamei M, Yang J, Tucker GT & Rostami-Hodjegan A

    Oct 2008

    Prediction of time-dependent CYP3A4-mediated in vivo drug-drug interactions from in vitro data using biological information on enzyme turnover implemented within a physiologically based model.
    15th North American ISSX Meeting.
    October 12th-16th 2008, San Diego, California.

    Available to Members only, click to login.

  • Johnson TN, Boussery K, Tucker GT & Rostami-Hodjegan A

    May 2008

    Prediction of the increased exposure to drugs in liver cirrhosis: a systems biology approach integrating prior information on disease with in vitro data on drug disposition.
    10th European ISSX Meeting.

    May 18th–21st 2008, Vienna, Austria.

    Available to Members only, click to login.

  • Polak S, Jamei M, Turner DB, Yang J, Neuhoff S, Tucker GT & Rostami-Hodjegan A

    May 2008

    Prediction of the in vivo behaviour of modified release formulations of metoprolol from in vitro dissolution profiles using the ADAM model (Simcyp V8).
    10th European ISSX Meeting.
    May 18th–21st 2008, Vienna, Austria.

    Available to Members only, click to login.

  • Neuhoff S, Yang J, Jamei M, Tucker GT & Rostami-Hodjegan A

    May 2008

    Simulation of the effect of P-glycoprotein on drug absorption in the human gastrointestinal tract.
    10th European ISSX Meeting.
    May 18th -21st 2008, Vienna, Austria.

    Available to Members only, click to login.

  • Neuhoff S, Barter ZE, Rowland-Yeo K, Tucker GT & Rostami-Hodjegan A

    May 2008

    In vitro-in vivo extrapolation of the clearance of drugs by glucuronidation: scaling factors for recombinant UGT1A1 data.
    10th European ISSX Meeting.
    May 18th -21st 2008, Vienna, Austria.

    Available to Members only, click to login.

  • Yang J, Liao M, Shou M, Jamei M, Rowland-Yeo K, Tucker GT & Rostami-Hodjegan A

    May 2008

    Cytochrome P450 turnover: methods for determining rates and implications for the prediction of drug interactions.
    2nd Asian Pacific ISSX Meeting.
    May 11th-13th 2008, Shanghai, China.

    Available to Members only, click to login.

  • Crewe HK, Barter ZE, Rowland-Yeo K, Tucker GT & Rostami-Hodjegan A

    May 2008

    Comparison of the catalytic activity per unit enzyme of recombinantly expressed and human liver microsomal cytochrome P450 2C9: determination of inter system extrapolation factors
    10th European ISSX Meeting.

    May 18th–21st 2008, Vienna, Austria.

    Available to Members only, click to login.

  • Perrett HF, Barter ZE, Lennard MS, Tucker GT & Rostami-Hodjegan A

    May 2008

    What is the level of expression of CYP2D6 in human liver? Influence of different calibration standards of the estimation of CYP2D6 abundance.
    10th European ISSX Meeting.
    May 18th–21st 2008, Vienna, Austria.

    Available to Members only, click to login.

  • Johnson TN, Boussery K, Polak S, Tucker GT & Rostami-Hodjegan, A

    Mar 2008

    Mechanistic models of human pharmacokinetics to predict the effects of liver cirrhosis on the clearance of nine drugs.
    American Conference on Pharmacometrics.
    March 9th-12th 2008, Tucson, Arizona, USA.

    Available to Members only, click to login.

box top

Workshops


Please click here to view our upcoming workshops.
see more
Need more help?

Consortium members and associates include: